The table below shows GeneDx Holdings Corp.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$102.25M
$116.74M
$102.69M
$87.11M
$76.87M
$70.51M
Cost of revenue
$34.04M
$32.22M
$31.79M
$28.64M
$29.05M
$27.56M
Gross profit
$68.21M
$84.53M
$70.90M
$58.48M
$47.83M
$42.95M
R&D
$19.80M
$19.83M
$15.08M
$12.58M
$11.66M
$10.90M
WGS annual revenue (10-K history)
GeneDx Holdings Corp. reported annual revenue of $427.54M for fiscal year 2025. That is up 40.0% from $305.45M in fiscal 2024. Over the 7 fiscal years shown, annual revenue grew from $196.17M (FY 2019) to $427.54M. Figures come from the company's audited annual reports as filed with the SEC.